Alexandre Lugat, physician in the nuclear medicine department of the Nantes University Hospital, will lecture on “Targeted alpha therapy of endocrine neoplasias: relevance and state of clinical advancements”.
The nuclear medicine department of the Nantes University Hospital, the CRCI2NA nuclear oncology research team and the GIP ARRONAX are involved in the RHU OPERANDI, which aims to develop innovative approaches to improve targeted radionuclide therapy for certain digestive cancers.